Home  /  Investors   /  Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 24 out of 24 posts.
18 Dec, 2014
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
20 Nov, 2014
XVIVO obtains financing from Vinnova for cancer research
24 Oct, 2014
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
17 Oct, 2014
Conference call interim report
16 Oct, 2014
Election Committee of XVIVO Perfusion AB (publ)
30 Sep, 2014
Installation of the first XPS™ in Asia
19 Sep, 2014
XVIVO receives Horizon 2020 funding
13 Aug, 2014
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
13 Aug, 2014
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
7 Aug, 2014
Conference call interim report
7 Jul, 2014
Share warrant program fully subscribed
26 Jun, 2014
XVIVO has completed a private placement of shares
25 Jun, 2014
XVIVO intends to undertake a private placement of shares
30 Apr, 2014
REPORT FROM ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
23 Apr, 2014
Interim Report January – March 2014
14 Apr, 2014
Conference call interim report
7 Apr, 2014
Annual report 2013
31 Mar, 2014
XPS™ has received CE mark
28 Mar, 2014
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
21 Mar, 2014
The FDA Advisory Panel voted unanimously that XPS™ with STEEN Solution™ meets the requirements for HDE
14 Mar, 2014
Progress made in the NOVEL study in the USA
7 Feb, 2014
Report on Operations 2013
29 Jan, 2014
XVIVO expands the US study with another leading transplant center
28 Jan, 2014
Conference call on Report on Operations 2013

Fill out the form to watch the video